Investors

Stock Info
OTCQBWIZP
News
Feb 20, 2020

Wize Pharma, Inc. (OTCQB: WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced it has completed its previously announced strategic...

Jan 21, 2020

Wize Pharma, Inc. (OTCQB: WIZP) ("Wize"), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced it has completed enrolment in its Phase IV...

Jan 16, 2020

Wize Pharma, Inc. (OTCQB: WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced that it has entered into a strategic transaction with...

More News

SEC Filings
0001218683
Investor Presentation
Planned Move Into Non-Viral Gene Therapy

Subscribe For Alerts
* Required Fields